Detalles de la búsqueda
1.
miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap.
J Biol Chem
; 299(12): 105478, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981211
2.
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus.
Diabetes Obes Metab
; 26(1): 262-274, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37828829
3.
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab
; 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38764356
4.
Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients.
Diabetes Obes Metab
; 25(5): 1271-1279, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633511
5.
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis.
Clin Exp Nephrol
; 27(7): 639-647, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36977892
6.
Effects of a High-Protein Diet on Kidney Injury under Conditions of Non-CKD or CKD in Mice.
Int J Mol Sci
; 24(9)2023 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37175483
7.
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.
Clin Exp Nephrol
; 26(10): 988-996, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35751753
8.
Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice.
Int J Mol Sci
; 22(22)2021 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830314
9.
Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain.
Hypertens Res
; 47(1): 55-66, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957242
10.
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Hypertens Res
; 47(3): 628-638, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37848562
11.
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
Front Pharmacol
; 15: 1358573, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601470
12.
Updates for Cardio-Kidney Protective Effects by Angiotensin Receptor-Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection.
J Am Heart Assoc
; 12(8): e029565, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37066800
13.
Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome.
Eur Heart J Open
; 3(6): oead098, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941728
14.
Angiotensin II type 1 receptor-associated protein in immune cells: a possible key factor in the pathogenesis of visceral obesity.
Metabolism
; 149: 155706, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37856903
15.
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Diab Vasc Dis Res
; 20(6): 14791641231222837, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096503
16.
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Cardiovasc Endocrinol Metab
; 12(4): e0292, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779602
17.
Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Front Pharmacol
; 13: 885457, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35662736
18.
Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis.
Clin Rheumatol
; 41(3): 911-919, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34642880
19.
Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
Diabetes Res Clin Pract
; 194: 110161, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36403681
20.
Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization.
Sci Rep
; 12(1): 17376, 2022 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36253401